Compass Pathways PLC
NASDAQ:CMPS
Compass Pathways PLC
Operating Income
Compass Pathways PLC
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Compass Pathways PLC
NASDAQ:CMPS
|
Operating Income
-$127.1m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Operating Income
-$171.3m
|
CAGR 3-Years
-154%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Operating Income
-$175.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Operating Income
-$179.9m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Operating Income
-£59.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Operating Income
£53m
|
CAGR 3-Years
8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
See Also
What is Compass Pathways PLC's Operating Income?
Operating Income
-127.1m
USD
Based on the financial report for Dec 31, 2023, Compass Pathways PLC's Operating Income amounts to -127.1m USD.
What is Compass Pathways PLC's Operating Income growth rate?
Operating Income CAGR 5Y
-59%
Over the last year, the Operating Income growth was -28%. The average annual Operating Income growth rates for Compass Pathways PLC have been -42% over the past three years , -59% over the past five years .